Maria Igotti

Dr. Maria Igotti

Institute of Cytology, Saint Petersburg, Sankt-Peterburg, Russia
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Olga GnedinaOlga Gnedina
Olga Gnedina
Alisa MorshnevaAlisa Morshneva
Alisa Morshneva
ESElena Skvortsova
Elena Skvortsova
Maria IgottiMaria Igotti
Maria Igotti
Many cancer therapy strategies cause DNA damage leading to the death of tumor cells. The DNA damage response (DDR) modulators are considered as promising candidates for use in combination therapy to enhance the efficacy of DNA-damage-mediated cancer treatment. The inhibitors of histone deacetylases (HDACis) exhibit selective antiproliferative effects against transformed and tumor cells and could enhance tumor cell sensitivity to genotoxic agents, which is partly attributed to their ability to interfere with DDR. Using the comet assay and host-cell reactivation of transcription, as well as γH2AX staining, we have shown that sodium butyrate inhibited DNA double-strand break (DSB) repair of both endo- and exogenous DNA in transformed but not in normal cells. According to our data, the dysregulation of the key repair proteins, especially the phosphorylated Mre11 pool decrease, is the cause of DNA repair impairment in transformed cells. The inability of HDACis to obstruct DSB repair in normal cells shown in this work demonstrates the advantages of HDACis in combination therapy with genotoxic agents to selectively enhance their cytotoxic activity in cancer cells.

10 May 2018 in AIMS Genetics
Verified
Journal Article
Open access
PDF file
Alisa MorshnevaAlisa Morshneva
Alisa Morshneva
OGOlga Gnedina
Olga Gnedina
SSSvetlana Svetlikova
Svetlana Svetlikova
VPValery Pospelov
Valery Pospelov
Maria IgottiMaria Igotti
Maria Igotti
HDAC inhibitors (HDACIs) induce irreversible cell cycle arrest and senescence in mouse embryonic fibroblasts transformed with E1A and c-Ha-Ras oncogenes (E1A+Ras cell line). The aging rate has been associated with the production of high levels of Reactive Oxygen Species (ROS). Specific increases of ROS level have been demonstrated as potentially critical for induction and maintenance of cell senescence process. It's known that HDACs regulate the ROS-dependent FoxO factors, which are responsible for cell growth, proliferation, and longevity. The characteristic ROS increase during aging may be responsible for the decreased HDAC activity, which facilitates the senescent-like phenotype. The objective of this study was to investigate the impact of FoxO transcription factors on HDACIs-induced senescence of E1A+Ras oncogenes transformed cells. This study shows the specific time-dependent effect of HDACI sodium butyrate treatment on FoxO proteins in E1A+Ras cells. Indeed, short-term treatment with NaB results in FoxO activation, which takes place through nuclear translocation, and accompanied by accumulation of such ROS scavengers as MnSOD and SOD2. However, prolonged treatment leads to extensive FoxO degradation and increased intracellular levels of ROS. This degradation is connected with NaB-induced activation of Akt kinase. All of these findings establish that one of the possible mechanism involved in NaB-induced senescence of transformed cells is mediated through down-regulation of FoxO transcription factors and ROS accumulation.

1 June 2014 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
Maria IgottiMaria Igotti
Maria Igotti
APA.K. Pojidaeva
A.K. Pojidaeva
EFE.A. Filippova
E.A. Filippova
Olga GnedinaOlga Gnedina
Olga Gnedina
SSS.B. Svetlikova
S.B. Svetlikova
VPV.A. Pospelov
V.A. Pospelov

1 October 2018 in Acta Naturae
Verified
Journal Article
Open access
Maria IgottiMaria Igotti
Maria Igotti
SSS. B. Svetlikova
S. B. Svetlikova
VPV. A. Pospelov
V. A. Pospelov
The adenoviral E1A protein induces cell proliferation, transformation, and tumor formation in rodents, on the one hand. On the other hand, E1A expression increases cell sensitivity to a number of cytotoxic agents. Therefore, E1A is a candidate for use as a component of combination therapy for malignant tumors. The highest augmentation in the cytotoxic effect was achieved by a combined use of E1A expression and histone deacetylases (HDAC) inhibitors. However, HDAC inhibitors do not induce apoptosis in cells transformed with E1A and cHa-ras oncogenes. In this study, it was shown that HDAC inhibitors reduce the expression of adenoviral E1A. However, under unregulated E1A overexpression, these cells undergo apoptosis in the presence of HDAC inhibitors. Treatment with a HDAC inhibitor, sodium butyrate (NaBut), was shown to activate the anti-apoptotic factor NF-kB in control cells. However, NaBut was unable to modulate the NF-kB activity in E1A overexpressed cells. Therefore, it is fair to postulate that cells transformed with E1A and cHa-ras oncogenes avoid the apoptosis induced by HDAC inhibitors thanks to a NaBut-dependent decrease in E1A expression. KEYWORDS apoptosis; histone deacetylase inhibitors; E1A and cHa-ras oncogenes, transformed cells.

1 January 2023 in Citologiâ
Verified
Journal Article
Closed access
PDF file
OGO. O. Gnedina
O. O. Gnedina
AMA. V. Morshneva
A. V. Morshneva
Maria IgottiMaria Igotti
Maria Igotti
Previously, we have shown that inhibitors of histone deacetylases (HDIs) do not induce DNA double strand breaks (DNA DSBs). However, like genotoxic agents, HDIs initiate the accumulation of phosphorylated histone H2AX (γH2AX), which is a DNA DSB marker. HDIs can also reduce the efficiency of repair of DNA damaged by genotoxic effects in transformed cells. The aim of this work was to identify the signaling pathways leading to the accumulation of γH2AX under the HDIs treatment in transformed cells. There was considered the role of the MAPK family kinases in phosphorylation of histone H2AX as well as inhibition of DNA repair induced with HDI sodium butyrate (NaBut). It was shown that the accumulation of γH2AX under the NaBut treatment is accompanied by a decrease of the ERK and PKB/Akt kinases phosphorylation level in transformed cells. The activating phosphorylation of p38 kinase increases under the NaBut treatment, causing Wip1 phosphatase accumulation, which may be one of the reasons for the DNA repair inhibition. Suppression of p38 kinase activity abolishes the NaBut-induced inhibition of repair efficiency. The data obtained suggest the role of the p38/Wip1 pathway in the HDIs-induced decrease in repair efficiency in transformed cells.

30 December 2019 in Cells
Verified
Journal Article
Open access
PDF file
Alisa MorshnevaAlisa Morshneva
Alisa Morshneva
Olga GnedinaOlga Gnedina
Olga Gnedina
TMTamara Marusova
Tamara Marusova
Maria IgottiMaria Igotti
Maria Igotti
The adenoviral early region 1A (E1A) protein has proapoptotic and angiogenic activity, along with its chemosensitizing effect, making it the focus of increased interest in the context of cancer therapy. It was previously shown that E1A-induced chemosensitization to different drugs, including histone deacetylases inhibitors (HDACi), appears to be mediated by Forkhead box O (FoxO) transcription factors. In this study, we explore the relationship between E1A expression and the modulation of FoxO activity with HDACi sodium butyrate (NaBut). We show here that the basal FoxO level is elevated in E1A-expressing cells. Prolonged NaBut treatment leads to the inhibition of the FoxO expression and activity in E1A-expressing cells. However, in E1A-negative cells, NaBut promotes the transactivation ability of FoxO over time. A more detailed investigation revealed that the NaBut-induced decrease of FoxO activity in E1A-expressing cells is due to the NaBut-dependent decrease in E1A expression. Therefore, NaBut-induced inhibition of FoxO in E1A-positive cells can be overcome under unregulated overexpression of E1A. Remarkably, the CBP/p300-binding domain of E1Aad5 is responsible for stabilization of the FoxO protein. Collectively, these data show that the expression of E1A increases the FoxO stability but makes the FoxO level more sensitive to HDACi treatment.